COVID-19 Video Series - Myeloma Patients Europe

EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE

Back to COVID-19

COVID-19 Video Series

MPE is developing a COVID-19 video series to gather information from top experts on how COVID-19 is affecting myeloma and AL amyloidosis treatment and clinical trials. Hear from experts how different countries and hospitals are managing the COVID-19 crisis:

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

play-claro

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations

Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.

MPE Publications

<img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img class="vc_single_image-img " src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/"/>

Tips for patients

<img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img class="vc_single_image-img " src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/"/>

Global Information

<img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img class="vc_single_image-img " src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/"/>

National Information

<img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img class="vc_single_image-img " src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/"/>

COVID-19 Video Series

<img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/" data-src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" class="vc_single_image-img lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img class="vc_single_image-img " src="https://www.mpeurope.org/wp-content/uploads/2021/11/flecha_weblink-25x25.png" width="25" height="25" alt="flecha_weblink" title="flecha_weblink" data-dt-location="https://www.mpeurope.org/capacity-building-advocacy/flecha_weblink/"/>

MPE Telegram channel on COVID-19

Subscribe to

our newsletter!